Leukemia, Erythroblastic, Acute
Showing 1 - 25 of >10,000
Leukemia, Erythroblastic, Acute, MDS Trial in New York (5-Azacytidine, Fludarabine, Melphalan)
Completed
- Leukemia, Erythroblastic, Acute
- Myelodysplastic Syndromes
- 5-Azacytidine
- +4 more
-
New York, New YorkWeill Cornell Medical College
Aug 25, 2021
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +15 more
- trebananib
- +3 more
-
Buffalo, New York
- +1 more
Sep 8, 2022
Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Atlanta,
Terminated
- Adult Acute Basophilic Leukemia
- +16 more
- eltrombopag olamine
- standard follow-up care
-
Atlanta, Georgia
- +1 more
Jul 20, 2022
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +13 more
- Sirolimus
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 2, 2023
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Basophilic Leukemia, Adult
Active, not recruiting
- Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
- +18 more
- eltrombopag olamine
-
Cleveland, OhioCase Comprehensive Cancer Center
Nov 29, 2021
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia
Completed
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +14 more
- Aldesleukin
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,
Recruiting
- Acute Erythroid Leukemia
- +10 more
- Fludarabine
- +5 more
-
San Francisco, California
- +5 more
Nov 1, 2022
Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,
Terminated
- Acute Biphenotypic Leukemia
- +29 more
- Cyclophosphamide
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 4, 2023
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Terminated
- Adult Acute Megakaryoblastic Leukemia (M7)
- +15 more
- fludarabine phosphate
- +4 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Aug 20, 2021
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +16 more
- choline magnesium trisalicylate
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Aug 20, 2021
Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States
Completed
- Acute Myeloid Leukemia
- +19 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Lewes, Delaware
- +16 more
Aug 3, 2022
Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in United
Completed
- Adult Acute Basophilic Leukemia
- +16 more
-
Little Rock, Arkansas
- +53 more
Jan 13, 2022
Refractory Acute Myeloid Leukemia, Relapsed Acute Erythroid Leukemia, Salvage Treatment Trial in Guangzhou (HVA Regimens as
Enrolling by invitation
- Refractory Acute Myeloid Leukemia
- +3 more
- HVA Regimens as Salvage Treatment
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Jun 7, 2020
Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6) Trial in
Completed
- Childhood Acute Basophilic Leukemia
- +14 more
- asparaginase
- +5 more
-
Phoenix, Arizona
- +96 more
Jan 20, 2022
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +16 more
- standard follow-up care
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Jul 29, 2020
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +16 more
- azacitidine
- +3 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
May 13, 2020
Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States
Active, not recruiting
- Acute Myeloid Leukemia
- +13 more
- Azacitidine
- Gemtuzumab Ozogamicin
-
Burbank, California
- +176 more
Mar 25, 2022
Acute Myeloid Leukemia Trial in Antalya
Recruiting
- Acute Myeloid Leukemia
-
Antalya, TurkeyAntalya Training and Research Hospital
Jul 29, 2023
Frequency and Risk Factors of Acute Myeloid Leukemia
Not yet recruiting
- Myeloid Leukemia
- Bone marrow aspirite for diagnosis
- (no location specified)
Mar 15, 2023
Patients With Acute Myeloid Leukemia
Recruiting
- Acute Myeloid Leukemia, Adult
-
Freiburg, CA, GermanyMedical Center- University of Freiburg
Aug 4, 2023
The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding
Completed
- Leukemia, Acute
- (no location specified)
Jul 23, 2023
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)
Recruiting
- Acute Myeloid Leukemia Refractory
- Acute Myeloid Leukemia, in Relapse
- anti Tim-3/CD123 CAR-T cell therapy
-
Xuzhou, Jiangsu, ChinaKailin Xu
Nov 4, 2023
H19 in Acute Lymphoblastic Leukemia.
Not yet recruiting
- Acute Lymphoid Leukemia
- (no location specified)
Jul 11, 2023
Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)
Recruiting
- Acute Myeloid Leukemia
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jun 23, 2023